Acute Coronary Syndrome (ACS) | Norton Healthcare

Indication: Acute Coronary Syndrome (ACS)

A Phase 3, Multicenter, Double-blind, Randomized, Placebo-controlled, Parallel-group Study to Investigate the Efficacy and Safety of CSL112 in Subjects with Acute Coronary Syndrome

Sub-indication: Acute Coronary Syndrome (ACS)

Study Type: Drug Study

Principal Investigator: Vipul Panchal, M.D.
Norton Heart & Vascular Institute

Sponsor: Sponsor: CSL Behring LLC

Learn more at

Email for more information:

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.